Development of a nucleic acid-based lateral flow device as a reliable diagnostic tool for respiratory viral infections

Viral infections continue to pose a significant threat to the public health, leading to high morbidity and mortality rates worldwide. To combat these challenges, early detection and treatment are essential in reducing hospitalizations and preventing severe complications. Simple, inexpensive, and sen...

Full description

Bibliographic Details
Main Authors: Pınar Akalın, Ayten Yazgan-Karataş
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:MethodsX
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2215016123003680
_version_ 1797405465589579776
author Pınar Akalın
Ayten Yazgan-Karataş
author_facet Pınar Akalın
Ayten Yazgan-Karataş
author_sort Pınar Akalın
collection DOAJ
description Viral infections continue to pose a significant threat to the public health, leading to high morbidity and mortality rates worldwide. To combat these challenges, early detection and treatment are essential in reducing hospitalizations and preventing severe complications. Simple, inexpensive, and sensitive diagnostic methods are in constant demand in many areas. In this study, we report the development of a nucleic acid-based lateral flow immunoassay device (NALFIA) and demonstrate its successful application in conjunction with a multiplexed reverse-transcription loop-mediated isothermal amplification assay (LAMP) for the detection of SARS-CoV-2 and influenza. In our approach the NALFIA part preparation is independent of the target, and has the potential to ensure widespread use in diagnostics particularly where testing speed is critical such as in respiratory viral infections. • Simple, inexpensive, sensitive and reliable rapid diagnostic tool. • Target independent design. • Effective use for respiratory samples due to practical sample extraction.
first_indexed 2024-03-09T03:10:18Z
format Article
id doaj.art-cf66cfa61dc04748995b37881491b71b
institution Directory Open Access Journal
issn 2215-0161
language English
last_indexed 2024-03-09T03:10:18Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series MethodsX
spelling doaj.art-cf66cfa61dc04748995b37881491b71b2023-12-04T05:22:29ZengElsevierMethodsX2215-01612023-12-0111102372Development of a nucleic acid-based lateral flow device as a reliable diagnostic tool for respiratory viral infectionsPınar Akalın0Ayten Yazgan-Karataş1Dr. Orhan Öcalgiray Molecular Biology, Biotechnology and Genetics Research Center (ITU-MOBGAM), Istanbul Technical University, Maslak 34469, Istanbul, Turkey; Corresponding author.Dr. Orhan Öcalgiray Molecular Biology, Biotechnology and Genetics Research Center (ITU-MOBGAM), Istanbul Technical University, Maslak 34469, Istanbul, Turkey; Faculty of Science and Letters, Department of Molecular Biology and Genetics, Istanbul Technical University, Maslak 34469 Istanbul, TurkeyViral infections continue to pose a significant threat to the public health, leading to high morbidity and mortality rates worldwide. To combat these challenges, early detection and treatment are essential in reducing hospitalizations and preventing severe complications. Simple, inexpensive, and sensitive diagnostic methods are in constant demand in many areas. In this study, we report the development of a nucleic acid-based lateral flow immunoassay device (NALFIA) and demonstrate its successful application in conjunction with a multiplexed reverse-transcription loop-mediated isothermal amplification assay (LAMP) for the detection of SARS-CoV-2 and influenza. In our approach the NALFIA part preparation is independent of the target, and has the potential to ensure widespread use in diagnostics particularly where testing speed is critical such as in respiratory viral infections. • Simple, inexpensive, sensitive and reliable rapid diagnostic tool. • Target independent design. • Effective use for respiratory samples due to practical sample extraction.http://www.sciencedirect.com/science/article/pii/S2215016123003680Universal-NALFIA U-NALF
spellingShingle Pınar Akalın
Ayten Yazgan-Karataş
Development of a nucleic acid-based lateral flow device as a reliable diagnostic tool for respiratory viral infections
MethodsX
Universal-NALFIA U-NALF
title Development of a nucleic acid-based lateral flow device as a reliable diagnostic tool for respiratory viral infections
title_full Development of a nucleic acid-based lateral flow device as a reliable diagnostic tool for respiratory viral infections
title_fullStr Development of a nucleic acid-based lateral flow device as a reliable diagnostic tool for respiratory viral infections
title_full_unstemmed Development of a nucleic acid-based lateral flow device as a reliable diagnostic tool for respiratory viral infections
title_short Development of a nucleic acid-based lateral flow device as a reliable diagnostic tool for respiratory viral infections
title_sort development of a nucleic acid based lateral flow device as a reliable diagnostic tool for respiratory viral infections
topic Universal-NALFIA U-NALF
url http://www.sciencedirect.com/science/article/pii/S2215016123003680
work_keys_str_mv AT pınarakalın developmentofanucleicacidbasedlateralflowdeviceasareliablediagnostictoolforrespiratoryviralinfections
AT aytenyazgankaratas developmentofanucleicacidbasedlateralflowdeviceasareliablediagnostictoolforrespiratoryviralinfections